Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1.

Saved in:
Bibliographic Details
Title: Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1.
Authors: Reuss JE; Georgetown University, Washington, DC., Kuruvilla S; London Health Sciences Centre, London, ON, Canada., Ismaila N; American Society of Clinical Oncology (ASCO), Alexandria, VA., Azar IH; IHA Hematology Oncology Consultants, Ypsilanti, MI., Feldman J; EGFR Resisters Patient Advocacy Group, Deerfield, IL., Furuya N; St Marianna University School of Medicine, Kawasaki, Japan., Wheatley-Price P; The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada., Roof L; Ohio State University, Columbus, OH., Velazquez AI; University of California, San Francisco, CA., Wang Y; Lovelace Cancer Care, Albuquerque, NM., Leighl NB; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Aug 20; Vol. 43 (24), pp. e31-e44. Date of Electronic Publication: 2025 Jul 17.
Publication Type: Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-7755
DOI:10.1200/JCO-25-01061